[ Price : $8.95]
FDA and the National Center for Advancing Translational Sciences update the CURE ID crowd-sourcing drug repurposing app.[ Price : $8.95]
The LUNGevity Foundation says many lung cancer therapies are in development, including some relying on biomarkers.[ Price : $8.95]
FDA grants Mustang Bio an orphan drug designation for MB-106, a CD20-targeted, autologous CAR T cell therapy for treating Waldenst...[ Price : $8.95]
U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) reveal bipartisan legislation entitled Improving Needed Safeguards fo...[ Price : $8.95]
Two drug stakeholder associations ask FDA to reconsider its proposal that opioid manufacturers provide mail-back envelopes to use ...[ Price : $8.95]
BD says it is recalling intraosseous products that have several issues.[ Price : $8.95]
The Menarini Group submits an NDA for elacestrant and its use in patients with ER+/HER2 advanced or metastatic breast cancer.[ Price : $8.95]
CBER updates its guidance agenda for 2022 containing 18 guidances it plans to develop.